Low mortality in burned patients in a Pseudomonas vaccine trial.
In a controlled clinical trial of a polyvalent pseudomonas vaccine in burned patients infected with Pseudomonas aeruginosa all 18 vaccinated patients survived, whereas 8 of 20 unvaccinated patients died.
D000293:Adolescent; D000328:Adult; D001428:Bacterial Vaccines / Q000627:therapeutic use*; D002056:Burns / Q000150:complications / Q000401:mortality*; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D006801:Humans; D007223:Infant; D008875:Middle Aged; D011552:Pseudomonas Infections / Q000209:etiology / Q000517:prevention & control*; D011550:Pseudomonas aeruginosa / Q000302:isolation & purification; D014946:Wound Infection / Q000209:etiology / Q000382:microbiology / Q000517:prevention & control*
D001428:Bacterial Vaccines